Novel APIs require innovative solutions. Download this whitepaper to learn how established lipid chemistries offer a safe, scalable approach to accelerate your next tablet formulation to market.
In this Contract Pharma VideoBite, Evotec’s team reveals how flexible innovation is unlocking improved solubility and bioavailability for complex molecules across modern drug development.
Aims to streamline the development of therapeutic antibodies by combining discovery, optimization and early functional testing into a single, integrated workflow.
QCL is a CDMO privately owned and operated since 1998. We excel in pre-formulation, formulation development, and delivering early phase clinical trial materials on aggressive timelines. We provide analytical development and validation, stability studies, and testing of small and large molecule APIs, finished products, and raw materials. New construction doubles our footprint to 200,000 sq. ft., expanding services into late phase clinical and small scale commercial GMP manufacturing including state of the art sterile fill-finish for both small and large molecules.
UI Pharmaceuticals, an FDA-registered, university-affiliated pharmaceutical manufacturing facility, has been a trusted partner since 1974. We provide comprehensive development, manufacturing, and testing services for sterile solutions, lyophilized products, tablets, capsules, and other forms, ensuring quality, compliance, and client satisfaction.
